NINA MARIE BARRAGAN: Open Payments
NPI 1366956476 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 8 payments from 4 companies in 2025. Trend: 2023 $744 · 2024 $684 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $193 |
| ABBVIE INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $25 |
Products named: Trodelvy, EPKINLY, ENHERTU, KISQALI.
Industry payments across CA — which companies pay providers there.
